Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121788074 | 12178807 | 4 | F | 20150919 | 20160728 | 20160315 | 20160728 | EXP | MX-ROCHE-1639787 | ROCHE | 55.93 | YR | F | Y | 72.50000 | KG | 20160728 | MD | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121788074 | 12178807 | 1 | PS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | LOADING DOSE | 1147117,1149553 | 125409 | 840 | MG | 1X | ||||||
| 121788074 | 12178807 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | MAINTENANCE DOSE?DATE OF MOST RECENT DOSE OF PERTUZUMAB PRIOR TO AE ONSET: 17/SEP/2015?DATE OF MOST | 1147117,1149553 | 125409 | 420 | MG | SOLUTION FOR INFUSION | Q3W | |||||
| 121788074 | 12178807 | 3 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | LOADING DOSE | 1145825 | 103792 | 8 | MG/KG | SOLUTION FOR INFUSION | 1X | |||||
| 121788074 | 12178807 | 4 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | MAINTENANCE DOSE?DATE OF MOST RECENT DOSE OF TRASTUZUMAB PRIOR TO AE ONSET: 17/SEP/2015?DATE OF MOST | 1145825 | 103792 | 480 | MG | SOLUTION FOR INFUSION | Q3W | |||||
| 121788074 | 12178807 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | DATE OF MOST RECENT DOSE OF TAXANE PRIOR TO AE ONSET: 17/SEP/2015?DATE OF MOST RECENT DOSE OF TAXANE | 0 | 91 | MG | Q3W | |||||||
| 121788074 | 12178807 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | |||||||||||
| 121788074 | 12178807 | 7 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | 0 | |||||||||||
| 121788074 | 12178807 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121788074 | 12178807 | 1 | HER-2 positive breast cancer |
| 121788074 | 12178807 | 3 | HER-2 positive breast cancer |
| 121788074 | 12178807 | 5 | HER-2 positive breast cancer |
| 121788074 | 12178807 | 6 | HER-2 positive breast cancer |
| 121788074 | 12178807 | 7 | HER-2 positive breast cancer |
| 121788074 | 12178807 | 8 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121788074 | 12178807 | HO |
| 121788074 | 12178807 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121788074 | 12178807 | Dehydration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121788074 | 12178807 | 1 | 20150827 | 0 | ||
| 121788074 | 12178807 | 2 | 20150917 | 0 | ||
| 121788074 | 12178807 | 3 | 20150827 | 0 | ||
| 121788074 | 12178807 | 4 | 20150917 | 0 | ||
| 121788074 | 12178807 | 5 | 20150827 | 0 | ||
| 121788074 | 12178807 | 6 | 20150529 | 0 | ||
| 121788074 | 12178807 | 7 | 20150529 | 0 | ||
| 121788074 | 12178807 | 8 | 201408 | 0 |